Business Wire

ALIBABA-GROUP

17.9.2020 07:02:08 CEST | Business Wire | Press release

Share
Alibaba Cloud Digitalizes Sports Events with More AI Solutions

During Apsara Conference 2020, the digital technology and intelligence backbone of Alibaba Group, unveiled a series of artificial intelligence (AI) powered solutions which are set to transform and digitalize the way sports entertainment was traditionally organized, broadcast and consumed. The solutions are designed to bring spectators closer to the events’ center stage for more personalized and interactive engagement, while helping organizers and broadcasters operate more efficiently, effectively and securely.

Event organizers are set to benefit considerably from Alibaba Cloud’s Event Simulation Services (ESS) . Running on cloud and powered by elastic compute, ESS can help organizers plan the layout of indoor venues virtually, optimizing the position of equipment and facilities, without having to move or commission a single piece of physical kit. With the ability to create a digital twin, ESS negates the time, expense and risk of physical tests and run-throughs, providing a comprehensive digital examination of a venue for all key stakeholders. When it comes to event broadcasting planning, ESS enables broadcasters to simulate and test different camera positions before installing camera tracks, thereby offering audiences the best point of view. Furthermore, ESS provides organizers with a wealth of insights for post-event analysis for more effective future planning.

For large-scale events, crowd management and access control could be time-consuming and cumbersome to coordinate. The typical paper-based accreditation system is not effective enough, especially at a time when venue coordinators are working hard to maintain social distancing measures.

Alibaba Cloud has developed a Digital Badge System which embeds access control and essential event information with digital accreditation. Developed to be simple to use, the digital badge system negates the need to print a paper ticket, not only being more environmentally friendly, but also reducing the risk of access pass counterfeiting. When using the digital badge, cards that carry important information such as maps, event times and organizer contact details, can be issued within seconds and on demand, removing the inventory problems often associated with paper-based systems. Card holders can also receive card expiration notices and other important notifications in real-time. In addition, event organizers have the option to embed health advisory information in the event of COVID-19 outbreaks.

Broadcasters and journalists are imperative in bringing the joy and excitement of sports stories to fans around the world. To improve their experience when attending press conferences, Alibaba Cloud has launched Press Conference on Cloud to facilitate virtual media briefings using proven live and on-demand streaming technologies. The solution broadens the reach and increases efficiency for journalists, who do not need to be physically present in order to join press conferences, saving them valuable time in crafting news stories, as well as the hassles of travelling to different venues in gigantic sports parks. Furthermore, with Press Conference on Cloud, reporters may even choose to attend more than one briefing happening in different locations at the same time to maximise their efficiency and productivity.

To bring fans closer to sports events, Alibaba Cloud also launched Fan Video Hub to enable sports fans from all over the world to support their favourite teams and athletes more personally, regardless of their location. The AI-powered technology can act as an efficient aggregator, which is able to collect and filter real-time videos uploaded by fans from all over the world to a variety of social network platforms, before broadcasting them onto designated online platforms, or in venues where the event being enjoyed is going on. Organizers of sports events can initiate special projects, encouraging fans to create motivating and personalized videos that will eventually be displayed in sports stadiums.

“As a global leading cloud service provider, we are excited to see our mature technology innovations to be used to support the digital transformation of some of the largest international sports events,” said Selina Yuan, President of International Business, Alibaba Cloud Intelligence. “For example, with Alibaba Cloud’s trusted infrastructure and services, we are able to work with stadiums and event managers to create even more thrilling and immersive experiences for fans, wherever they’re based. More importantly, health and safety has to be front of mind at all venues and events, and our solutions help event organizers deliver on their post-pandemic responsibilities through reduced and unnecessary travel. We want to maximize the thrill of sporting achievements, while enabling event organizers to work safely and even more efficiently with fans and global broadcasters.”

Alibaba Cloud is committed to digitalizing sports events through helping broadcasters revolutionalize the experience. In September 2018, together with Olympic Broadcasting Services (OBS), Alibaba Cloud launched OBS cloud, which was developed to transform the process for bringing the Olympic Games to viewers. Alibaba Cloud is also the official cloud services partner of the International Olympic Committee.

About Alibaba Cloud

Established in 2009, Alibaba Cloud (www.alibabacloud.com ), the digital intelligence and technology backbone of Alibaba Group, is among the world’s top three IaaS providers, according to Gartner, and the largest provider of public cloud services in China, according to IDC. Alibaba Cloud provides a comprehensive suite of cloud computing services to businesses worldwide, including merchants doing business on Alibaba Group marketplaces, start-ups, corporations and government organisations. Alibaba Cloud is the official Cloud Services Partner of the International Olympic Committee.

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release

Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he

Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release

Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co

Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release

Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth

Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release

Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th

CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release

The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye